Patent US4332814A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4332814A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of diarrhoea

Assignee: Beecham Group PLC
•
Filing: 1980-08-11
•
Granted: 1982-06-01
•
Expires: 2000-08-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Vasoconstrictor α-adrenergic agonists of formula (I) A--B--C (I) wherein, A is a 2-imidazoline group or a guanidine group; B is a chemical bond or a linking group one or two atoms in length; and C is a C 6-10 mono- or bi-cyclic group which is either an aromatic group, a heteroaromatic group containing only one hetero-atom, or a group containing an aromatic moiety; and which group C may be substituted by C 1-4 alkyl, C 1-4 alkoxy, halogen or hydroxyl; or salts thereof, are useful in the treatment and prevention of diarrhoea in livestock. Compositions of these compounds are described.

Inventors

  • 👤 Peter M. Newsome
  • 👤 Noel A. Mullen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 07:07
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/155; A61K31/33; A61K31/395; A61K31/41; A61K31/415; A61P; A61P1/00; A61P1/12

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 89 words
A method for treating diarrhoea in livestock, which comprises administering to livestock an amount effective to treat diarrhoea of a compound which is an α-adrenergic agonist and which has vasoconstrictor activity and is further characterized by formula (I): A--B--C (I) wherein A is 2-imidazolinyl or guanidinyl; B is selected from a direct bond, --CH 2 --, --CH 2 O--, --COCH 2 -- or --NH--; and C is phenyl, naphthyl, tetrahydronaphthyl or benzothienyl, unsubstituted or substituted by C 1-4 alkyl, C 1-4 alkoxy, halogen or hydroxy, or a salt thereof.
Claim 2
Independent Claim 89 words
A method for treating diarrhoea in livestock, which comprises administering to livestock an amount effective to treat diarrhoea of a compound which is an α-adrenergic agonist and which has vasoconstrictor activity and is further characterized by formula (I): A--B--C (I) wherein A is 2-imidazolinyl or guanidinyl; B is selected from a direct bond, --CH 2 --, --CH 2 O--, --COCH 2 -- or --NH--; and C is phenyl, naphthyl, tetrahydronaphthyl or benzothienyl, unsubstituted or substituted by C 1-4 alkyl, C 1-4 alkoxy, halogen or hydroxy, or a salt thereof.
Claim 3
Dependent Claim 25 words
The method according to claim 1, wherein the compound of formula (I) is administered as a veterinary composition in association with a veterinarily acceptable carrier.
Claim 4
Dependent Claim 20 words
The method according to claim 1, wherein said compound of formula (I) is selected from the group consisting of ##STR24##
Claim 5
Dependent Claim 23 words
The method according to claim 1, wherein said compound of formula (I) is administered in foodstuff or drinking water provided for the livestock.
Claim 6
Dependent Claim 18 words
The method according to claim 2, wherein said carrier is an orally administrable oil or water based cream.
Claim 7
Dependent Claim 18 words
The method according to claim 2, wherein said compound of formula (I) is administered in water by injection.
Claim 8
Dependent Claim 25 words
The method according to claim 2, wherein said compound of formula (I) is administered in multidosage form containing at least 5 g. of said compound.

References Cited (Backward Citations)

CA1072962A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-31 1985-11-30 1986-06-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-31 1989-11-30 1990-06-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-31 1993-11-30 1994-06-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag